ABIGO PHARMA A/S: Financial statements 2017
CVR: 12927983
Source: annual report 2017, Danish Business Authority
01/05/2016 – 30/04/2017
ABIGO PHARMA A/S (CVR 12927983) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK 5,325,623 and a net result of DKK 138,378 compared with DKK 642,085 the year before. That is a decrease of 7.6% compared with the year before. Equity in the 2017 report amounted to DKK -202,621.
- Gross Profit
- DKK 5,325,623
- Profit/Loss
- DKK 138,378
- Equity
- DKK -202,621
- Total Assets
- DKK 6,134,499
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | 5.3 mio. | 138 t. | -203 t. | - |
| 2016 | - | 5.8 mio. | 642 t. | -341 t. | - |
| 2015 | - | 3.5 mio. | 778 | -983 t. | - |
| 2014 | - | 2.8 mio. | 91 t. | -984 t. | - |
| 2013 | - | 2.7 mio. | 85 t. | -1.1 mio. | - |
Official annual report
Keep an eye on ABIGO PHARMA A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
As of March 29, 2017, Johan Lindberg is registered as suppleant of ABIGO PHARMA A/S.
As of March 29, 2017, Per-Oluf Nilsson has stepped down as suppleant of ABIGO PHARMA A/S.
About ABIGO PHARMA A/S
ABIGO PHARMA A/S was a Danish company of the type Aktieselskab based in Allerød, founded in 1989. The company has been dissolved on 27 June 2024. The company was registered under the industry Specialiseret engroshandel med fødevarer i.a.n.. The company was previously named DHC A/S and DANSK HELSEMIDDEL CENTER A/S. The company has 1 employee (2023). In 2023, the company reported revenue of DKK 9,189,036 and a net result of DKK 201,721 compared with DKK 165,903 the year before. Equity in the 2023 report amounted to DKK 4,838,794.